Entera Bio (ENTX) Other Non-Current Assets (2024 - 2026)

Entera Bio (ENTX) has reported Other Non-Current Assets for 3 consecutive years, with $7.8 million the latest figure, recorded in Q1 2026.

• Quarterly Other Non-Current Assets fell 2.62% year-over-year to $7.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.8 million (down 2.62% YoY) and the FY2025 annual result came in at $7.8 million, up 9618.75% from the prior year.
• Other Non-Current Assets held at $7.8 million in Q1 2026 per ENTX's latest filing, from $7.8 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for ENTX reached as high as $8.0 million in Q3 2025 and fell as low as $80000.0 in Q4 2024.
• A 3-year average of $6.6 million and a median of $7.9 million in 2025 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2025 — Other Non-Current Assets soared 9618.75% — and 2026, when it decreased 2.62%.
• Year by year, Other Non-Current Assets stood at $80000.0 in 2024, then surged by 9618.75% to $7.8 million in 2025, then climbed by 0.19% to $7.8 million in 2026.
• According to Business Quant data, Other Non-Current Assets over the past three periods registered $7.8 million, $7.8 million, and $8.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.